Thomas David Hull III Sells 773 Shares of Kewaunee Scientific (NASDAQ:KEQU) Stock

Kewaunee Scientific Corporation (NASDAQ:KEQU) CEO Thomas David Hull III sold 773 shares of the firm’s stock in a transaction on Friday, September 19th. The stock was sold at an average price of $45.34, for a total transaction of $35,047.82. Following the completion of the sale, the chief executive officer owned 43,294 shares in the company, valued at approximately $1,962,949.96. The trade was a 1.75% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Thomas David Hull III also recently made the following trade(s):

• On Thursday, September 18th, Thomas David Hull III sold 652 shares of Kewaunee Scientific stock. The stock was sold at an average price of $46.00, for a total transaction of $29,992.00.

Kewaunee Scientific Trading Down 1.2%

Shares of Kewaunee Scientific stock opened at $43.48 on Wednesday. The company’s fifty day simple moving average is $53.94 and its 200-day simple moving average is $45.49. The company has a market cap of $124.79 million, a price-to-earnings ratio of 10.53 and a beta of 0.75. The company has a current ratio of 2.32, a quick ratio of 1.63 and a debt-to-equity ratio of 0.88. Kewaunee Scientific Corporation has a 1 year low of $30.33 and a 1 year high of $71.33.

Kewaunee Scientific (NASDAQ:KEQU) last posted its quarterly earnings results on Wednesday, September 10th. The technology company reported $1.10 earnings per share for the quarter. Kewaunee Scientific had a net margin of 4.68% and a return on equity of 25.65%. The firm had revenue of $71.10 million for the quarter.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Saturday, July 5th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in KEQU. Jane Street Group LLC bought a new position in shares of Kewaunee Scientific during the fourth quarter valued at $300,000. Bank of America Corp DE lifted its holdings in shares of Kewaunee Scientific by 2,605.9% during the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock valued at $28,000 after acquiring an additional 443 shares during the period. Ritholtz Wealth Management lifted its holdings in shares of Kewaunee Scientific by 42.2% during the first quarter. Ritholtz Wealth Management now owns 17,949 shares of the technology company’s stock valued at $707,000 after acquiring an additional 5,330 shares during the period. IFP Advisors Inc lifted its holdings in shares of Kewaunee Scientific by 61.5% during the first quarter. IFP Advisors Inc now owns 945 shares of the technology company’s stock valued at $37,000 after acquiring an additional 360 shares during the period. Finally, American Century Companies Inc. lifted its holdings in shares of Kewaunee Scientific by 43.4% during the first quarter. American Century Companies Inc. now owns 49,182 shares of the technology company’s stock valued at $1,937,000 after acquiring an additional 14,889 shares during the period. 32.69% of the stock is owned by institutional investors.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.